Belle Mead, NJ, United States of America

Nilgun Ereken Tumer

This inventor holds 12 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent. Top assignees: Rutgers, The State University of New Jersey, Regents of the University of Minnesota, University of Medicine and Dentistry of New Jersey. Active years: 1998-2016.

USPTO Granted Patents = 12 

% Patents Active = 83.3


Average Co-Inventor Count = 1.6

ph-index = 3

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 1998-2016

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Innovations of Nilgun Ereken Tumer

Introduction

Nilgun Ereken Tumer is a prominent inventor based in Belle Mead, NJ (US). He has made significant contributions to the field of plant genetics and toxin treatment, holding a total of 12 patents. His work focuses on enhancing disease resistance in plants and developing methods for treating toxin poisoning.

Latest Patents

Among his latest patents are compositions and methods for modulating disease resistance in plants, specifically targeting plant genes that confer resistance to trichothecene mycotoxins and fusarium head blight. Additionally, he has developed compositions and methods for the treatment of toxin poisoning using ricin ribosome binding protein.

Career Highlights

Nilgun Ereken Tumer has worked with notable institutions such as Rutgers, The State University of New Jersey, and the Regents of the University of Minnesota. His research has significantly advanced the understanding of plant disease resistance and toxin treatment.

Collaborations

He has collaborated with esteemed colleagues, including Katalin A Hudak and Rong Di, who have contributed to his research endeavors.

Conclusion

Nilgun Ereken Tumer's innovative work in plant genetics and toxin treatment showcases his dedication to advancing agricultural science and public health. His contributions continue to impact the fields of plant resistance and toxin management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…